Acasti Pharma Inc EV/EBIT
Qual é o EV/EBIT de Acasti Pharma Inc?
O EV/EBIT de Acasti Pharma Inc é N/A
Qual é a definição de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de empresas na Setor Health Care em NASDAQ em comparação com Acasti Pharma Inc
O que Acasti Pharma Inc faz?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Empresas com ev/ebit semelhantes a Acasti Pharma Inc
- Halo Collective tem EV/EBIT de N/A
- Nkarta tem EV/EBIT de N/A
- Manugraph India tem EV/EBIT de N/A
- Guild Esports Plc tem EV/EBIT de N/A
- Clarity Gold tem EV/EBIT de N/A
- Radha Madhav tem EV/EBIT de N/A
- Acasti Pharma Inc tem EV/EBIT de N/A
- Akers Biosciences Inc tem EV/EBIT de N/A
- Agios Pharmaceuticals Inc tem EV/EBIT de N/A
- Generation Bio Co tem EV/EBIT de N/A
- Purple Biotech tem EV/EBIT de N/A
- Panbela Therapeutics tem EV/EBIT de N/A
- Continental Materials tem EV/EBIT de N/A